The Agency for Healthcare Research and Quality (AHRQ) is soliciting feedback to a series of questions that will help the Agency assess the clinical utility of pain management injections for low back pain. As part of AHRQ’s Technology Assessment Program, this information could be used by the Centers for Medicare and Medicaid Services to inform its national coverage decisions for the Medicare program as well as provide information to Medicare contractors. Comments will be accepted until March 3, 2014.
Submit comments to AHRQ.
Learn more about the Technology Assessment Program.
Read AHRQ’s Topic Refinement Document on Pain Management Injection Therapies for Low-back Pain.